<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>172</observationCode>
<observationTitle>Severe allergic reaction after previous dose of recombinant zoster</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of recombinant zoster vaccine.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>Zoster 2-dose series</seriesName>
<targetDisease>Zoster</targetDisease>
<vaccineGroup>Zoster </vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years</absMinAge>
<minAge>50 years</minAge>
<earliestRecAge>50 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>21; 94; 121</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>50 years - 4 days</absMinAge>
<minAge>50 years</minAge>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>21; 94; 121</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Zoster, unspecified formulation</vaccineType>
<cvx>188</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Zoster 3-dose series</seriesName>
<targetDisease>Zoster</targetDisease>
<vaccineGroup>Zoster </vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>50 years</absMinAge>
<minAge>60 years</minAge>
<earliestRecAge>60 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine/>
<allowableVaccine>
<vaccineType>Zoster live</vaccineType>
<cvx>121</cvx>
<beginAge>50 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Zoster, unspecified formulation</vaccineType>
<cvx>188</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Zoster Risk 2-dose series</seriesName>
<targetDisease>Zoster</targetDisease>
<vaccineGroup>Zoster </vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>1</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When possible, vaccination should be completed before transplantation. If not possible administer at least 6-12 months after transplantation at a time of stable graft function and on maintenance immunosuppression. Administer 3-12 months (after Autologous HCT) or 6-12 months (after Allogenic HCT) depending on timing of discontinuation of prophylactic antiviral therapy. Vaccination prior to discontinuation of antiviral therapy is preferred.</guidance>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, vaccination should be completed before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, vaccination should be completed before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Leukemia</text>
<code>178</code>
</observationCode>
<description>Administer to persons with leukemia.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Lymphoma</text>
<code>179</code>
</observationCode>
<description>Administer to persons with lymphoma.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Hodgkin's disease</text>
<code>180</code>
</observationCode>
<description>Administer to persons with Hodgkin's disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Multiple myeloma</text>
<code>181</code>
</observationCode>
<description>Administer to persons with multiple myeloma.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV Infection</text>
<code>186</code>
</observationCode>
<description>Administer to persons with HIV Infection</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>21; 94; 121</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>21; 94; 121</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Zoster recombinant</vaccineType>
<cvx>187</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Zoster, unspecified formulation</vaccineType>
<cvx>188</cvx>
<beginAge>18 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
